Christopher is a Partner based in Stockholm and joined Bridgepoint in 2007. He is a member of the Technology sector team.
He currently sits on the boards of Cherry, Diaverum and Vitamin Well. He has worked on a number of transactions including Vitamin Well, Cherry, Evac, Nordic Cinema Group, Trustly and Terveystalo.
Prior to joining Bridgepoint he worked in the investment banking division of UBS in London where he was involved in a number of cross border transactions.
Christopher has an MSc in Business Administration and Finance from Stockholm University, School of Business.
Si vous souhaitez postuler chez Bridgepoint, veuillez renseigner le formulaire ci-dessous.
Pour accéder aux rapports investisseurs sur notre portail web, vous devez renseigner le formulaire pour créer un compte.
Les informations contenues dans ce formulaire seront utilisées uniquement pour créer un compte utilisateur et ne seront pas divulguées à des tiers.